Effects of Sokmyong-tang on Ferric Chloride-induced Carotid Injury and Thrombosis in a Rat Model

경동맥 손상 및 혈전을 유발한 동물 모델에서 속명탕(續命湯)의 효능 검증

  • Heo, Eun Jung (Herbal Medicine Research Division, Korea Institute of Oriental Medicine) ;
  • Lee, In Sun (Herbal Medicine Research Division, Korea Institute of Oriental Medicine) ;
  • Kang, Hyung Won (Department of Neuropsychiatry, College of Oriental Medicine, Won-Kwang University) ;
  • Jeon, Won Kyung (Herbal Medicine Research Division, Korea Institute of Oriental Medicine)
  • 허은정 (한국한의학연구원 한의신약연구그룹) ;
  • 이인선 (한국한의학연구원 한의신약연구그룹) ;
  • 강형원 (원광대학교 한의과대학 한방신경정신과교실) ;
  • 전원경 (한국한의학연구원 한의신약연구그룹)
  • Received : 2012.09.12
  • Accepted : 2012.10.04
  • Published : 2012.10.25

Abstract

The aim of this study is examine the protection effect for artery and antithrombotic effect of Sokmyong-tang(SMT; xuming-tang) on carotid artery thrombosis in a rat model. Thirty minutes before $FeCl_3$ treatment, SD rats were intraperitoneal injected with SMT. We tested the effects of SMT on time to occlusion (TTO) in thrombosis model by induced $FeCl_3$ using the laser Doppler flow meter and accessed thrombus weight (TW) inhibition and measured collagen fibers in the vessel after injury using Masson's trichrome stain. SMT(100 mg/kg, i.p.) showed significantly delayed TTO ($13.17{\pm}1.33$ min, P < 0.001) compared to vehicle control group ($8.63{\pm}0.92$ min) and inhibiting effect on TW with $0.72{\pm}0.02$ mg/mm (P < 0.05). In addition, SMT prevented collagen fibres damage in injured vessel ($22.24{\pm}4.48%$, P < 0.001). These results provide experimental evidence for SMT can be used to prevent vascular injury and thrombosis such as hypertension, arteriosclerosis, and so on.

Keywords

Acknowledgement

Supported by : 기초기술연구회, 한국한의학연구원

References

  1. Yang, Y.Y., Lee, M.J., Lee, H.S., Park, W.H. Screening of antioxidative, anti-platelet aggregation and anti-thrombotic effects of Clove extracts. Korean J Oriental Physiology & Pathology. 25(3):471-481, 2011.
  2. Rader, D.J., Daugherty, A. Translating molecular discoveries into new therapies for atherosclerosis. Nature. 451: 904-913, 2008. https://doi.org/10.1038/nature06796
  3. Lee, H.S. How safe is the readministration of streptokinase? Drug Saf 13: 76-80, 1995. https://doi.org/10.2165/00002018-199513020-00002
  4. Burggraf, D., Vosko, M.R., Schubert, M., Stassen, J.M., Hamann, G.F. Different therapy options protecting microvasculature after experimental cerebral ischaemia and reperfusion. Thromb Haemost. 103(5):891-900, 2010. https://doi.org/10.1160/TH09-07-0500
  5. Baek, K.M., Roh, S.S. Effects of Aqueous extract of Diospyros Kaki Calyx on anti-thrombotic activity in vitro and in vivo. Kor J Herbology. 26(4):139-147, 2011.
  6. Wang Ang. YiFangJiJie. Seoul, DaXingWenHuaShe, pp 153-154, 1992.
  7. 李時珍. 本草鋼目. 上海, 上海科學技術出版社, pp 571-572, 1993.
  8. 李克光. 金櫃要略譯釋. 上海, 上海科學技術出版社, pp 137-138, 1993.
  9. Tohda, C., Tamura, T., Komatsu, K. Repair of amyloid ${\beta}$ (25-35)-induced memory impairment and synaptic loss by a Kampo formula, Zokumei-to. Brian Res. 990: 141-147, 2003. https://doi.org/10.1016/S0006-8993(03)03449-8
  10. Kurz, K.D., Main, B.W., Sandusky, G.E. Rat model of arterial thrombosis induced by ferric chloride. Thromb Res. 60: 269-280, 1990. https://doi.org/10.1016/0049-3848(90)90106-M
  11. Lee, I.S., Choi, S.G., Jeon, W.K. Optimization of ferric chloride induced carotid artery thrombosis model in a rat: Effect of Ginko biloba extracts. Kor J Clinical Laboratory Sciences. 43(4):179-187, 2011.
  12. Konstantinides, S., Schafer, K., Thinnes, T., Loskutoff, D.J. Plasminogen activator inhibitor-1 and its cofactor vitronectin stabilize arterial thrombi after vascular injury in mice. Circulation. 103: 576-583, 2001. https://doi.org/10.1161/01.CIR.103.4.576
  13. Yang, S.A., Im, N.K., Lee, I.S. Effect of methanolic extract from salvia miltiorrhiza bunge on in vitro antithrombotic and antioxidative activities. Kor J Food Science & Tech. 39: 83-87, 2007.
  14. Kung, H. Deaths: Final Data for 2005. National Vital Statistics Reports. p 56, 2005.
  15. Ross R. Atherosclerosis-an inflammatory disease. New Engl J Med. 340(2):115-126, 1999. https://doi.org/10.1056/NEJM199901143400207
  16. 이정희, 김숙희. 장기적인 인삼섭취가 인체의 혈전 관련 요인에 미치는 영향. 한국영양학회지 28(9):862-871, 2005.
  17. Mustard, J.F., Packham, M.A. Factors influencing platelet function:adhesion, release and aggregation. Pharmacol Rev. 22: 97-137, 1970.
  18. Blaha, M.J., Bansal, S., Rouf, R., Golden, S.H., Blumenthal, R.8., Defilippis, A.P. A practical "ABCDE" approach Lo the metabolic syndrome. Mayo Clin.Proc. 83: 932-941, 2008. https://doi.org/10.1016/S0025-6196(11)60770-2
  19. De Meyer SF, Vanhooelbbeke K. Broos KI. Anitplatelet drugs. British J Hamatology. 142: 515-528, 2008. https://doi.org/10.1111/j.1365-2141.2008.07233.x
  20. Liu, S., Jiang, S., Wu, Z., Lv, L., Zhang, J., Zhu, Z., Wu, S. Identification of inhibitors of the HIV-1 gp41 six-helix bundle formation from extracts of Chinese medicinal herbs. Prunella vulgaris and Rhizoma cibotte. Life Sci 71: 1779-1791, 2002. https://doi.org/10.1016/S0024-3205(02)01939-2
  21. 최승훈. 황제내경에서의 어혈의 인식에 대한 병리적 연구. 대전대학교논문집, 6(2):313-320, 2006.
  22. Jeon, W.K., Kim, H.K., Lee, J.H., Ko, B.S., Lee, A.Y., Lee, K.G., Shin, H.K. Study on anti-thrombotic activities of KIOM2003-080. Korea J Ori Med. 13(2):143-148, 2007.
  23. Kim, J.S., Kim, B.J., Kim, H.G., Ahan, J.C., Lee, S.K. Inhibi tory effects of Silsosangami on the platelet aggregation. Korean J Oriental Physiology & Pathology. 16(4):823-829, 2002.
  24. Lee, H.K., Lee, J.E., Jeong, J.H., Yoo, D.Y. Study on the effects of Gami-tonggyung-tang on antithrombotic, anti-inflammatory and analgesic action. J Oriental obstetrics & gynecology. 16(1):118-135, 2003.
  25. Park, T.W., Park, W.H. A study on anti-thrombotic activity of Hwao-tang. Korean J Oriental Med Physiology & Pathology. 16(1):181-185, 2002.
  26. 李德新. 氣血論. 遼寧省:遼寧科學技術出版社. p 161, 1990.